Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dana Miskulin

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 19, 2005
Characterizing comorbidity in dialysis patients: principles of measurement and applications in risk adjustment and patient careDana Miskulin
Nature Clinical Practice. Nephrology|February 28, 2007
Case-mix factors explain the survival advantage of Hispanic and racial minority patients on hemodialysisDana Miskulin
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 24, 2016
A β-Blocker Trial in Dialysis Patients: Is It Feasible and Worthwhile?Dana Miskulin, Mark Sarnak
Advances in Chronic Kidney Disease|February 24, 2015
Epidemiology of hypertension in CKDBruce Horowitz, Dana Miskulin, Philip Zager
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 26, 2020
High-Dose Versus Standard-Dose Influenza Vaccine in Hemodialysis PatientsDana Miskulin, Daniel E Weiner, Harold J Manley
Current Opinion in Nephrology and Hypertension|September 9, 2016
Intradialytic hypotensionAmbreen Gul, Dana Miskulin, Antonia Harford, et al.
Annals of Internal Medicine|February 8, 2012
Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic reviewAmy Earley, Dana Miskulin, Edmund J Lamb, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 11, 2010
Inflammation, oxidative stress, and insulin resistance in polycystic kidney diseaseVandana Menon, Darya Rudym, Priya Chandra, et al.
Kidney International|August 26, 2004
A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United StatesBraden Manns, Lesley Stevens, Dana Miskulin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 31, 2020
Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A ReviewMichael R Rudnick, Ihab M Wahba, Amanda K Leonberg-Yoo, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 19, 2005
Characterizing comorbidity in dialysis patients: principles of measurement and applications in risk adjustment and patient careDana Miskulin
Nature Clinical Practice. Nephrology|February 28, 2007
Case-mix factors explain the survival advantage of Hispanic and racial minority patients on hemodialysisDana Miskulin
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 24, 2016
A β-Blocker Trial in Dialysis Patients: Is It Feasible and Worthwhile?Dana Miskulin, Mark Sarnak
Advances in Chronic Kidney Disease|February 24, 2015
Epidemiology of hypertension in CKDBruce Horowitz, Dana Miskulin, Philip Zager
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 26, 2020
High-Dose Versus Standard-Dose Influenza Vaccine in Hemodialysis PatientsDana Miskulin, Daniel E Weiner, Harold J Manley
Current Opinion in Nephrology and Hypertension|September 9, 2016
Intradialytic hypotensionAmbreen Gul, Dana Miskulin, Antonia Harford, et al.
Annals of Internal Medicine|February 8, 2012
Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic reviewAmy Earley, Dana Miskulin, Edmund J Lamb, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 11, 2010
Inflammation, oxidative stress, and insulin resistance in polycystic kidney diseaseVandana Menon, Darya Rudym, Priya Chandra, et al.
Kidney International|August 26, 2004
A systematic review of sevelamer in ESRD and an analysis of its potential economic impact in Canada and the United StatesBraden Manns, Lesley Stevens, Dana Miskulin, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 31, 2020
Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A ReviewMichael R Rudnick, Ihab M Wahba, Amanda K Leonberg-Yoo, et al.
Pageof 4